Bavituximab Decreases Immunosuppressive Myeloid-Derived Suppressor Cells in Newly Diagnosed Glioblastoma Patients

Ina Ly(University of California San Diego), Elizabeth R. Gerstner(University of California, Los Angeles), James M. Brown(Mary Lyon Centre at MRC Harwell), Lakshmi Nayak(Dana-Farber Cancer Institute), Patrick Y. Wen(Dana-Farber Cancer Institute), Isabel Arrillaga‐Romany(Harvard University), Leland G. Richardson(Massachusetts General Hospital), Kevin Lou(Athinoula A. Martinos Center for Biomedical Imaging), Eudocia Q. Lee(Brigham and Women's Hospital), Jayashree Kalpathy–Cramer(University of Colorado Denver), Ken Chang(Harvard University), Andrew Beers(Massachusetts General Hospital), Bryan D. Choi(Harvard University), Jörg Dietrich(Massachusetts General Hospital), Mofei Liu(Dana-Farber Cancer Institute), Ugonma Chukwueke, William T. Curry(Harvard University), Justin T. Jordan(Massachusetts General Hospital), David A. Reardon(Dana-Farber Cancer Institute), Xiaoyue Ma(Athinoula A. Martinos Center for Biomedical Imaging), Tracy T. Batchelor(Brigham and Women's Hospital), Anita Giobbie‐Hurder(Institute for Tourism), Deborah Forst(Harvard University), Jonathan Cardona(Athinoula A. Martinos Center for Biomedical Imaging), Alona Muzikansky(Johns Hopkins University)
Clinical Cancer Research
June 16, 2023
Cited by 22


Related Papers